Cat. No. 1259
Chemical Name: (2R,3R,4R,5R)-2-(Hydroxymethyl)-3,4
Biological ActivitySelective inhibitor of α-mannosidase I.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Bischoff et al (1986) The use of 1-deoxymannojirimycin to evaluate the role of various α-mannosidases in oligosaccharide processing in intact cells. J.Biol.Chem. 261 4766. PMID: 2937779.
Bischoff and Kornfeld (1984) The effect of 1-deoxymannojirimycin on rat liver α-mannosidases. Biochem.Biophys.Res.Commun. 125 324. PMID: 6239623.
Fuhrmann et al (1984) Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature 307 755. PMID: 6230538.
If you know of a relevant reference for 1-Deoxymannojirimycin hydrochloride please let us know.
Citations are publications that use Tocris products. Selected citations for 1-Deoxymannojirimycin hydrochloride include:
Tareen et al (2014) Design of a novel integration-deficient lentivector technology that incorporates genetic and posttranslational elements to target human dendritic cells. Mol Ther 22 575. PMID: 24419083.
Do you know of a great paper that uses 1-Deoxymannojirimycin hydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: 1-Deoxymannojirimycin hydrochloride, supplier, α-mannosidase, alpha-mannosidase, I, inhibitors, inhibits, a-Mannosidase, Glycosylases, Carbohydrate, Metabolism, antibiotics, Tocris Bioscience, Glycosylase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and highly selective PDE5 inhibitor; orally bioavailable7-Ethoxyresorufin
Fluorometric CYP450 substrateGaleterone
CYP17 inhibitor; also androgen receptor antagonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.